ASTER DM HEALTHCARE LTD Q2 RESULTS
Olympus Capital Asia divests 9% stake in Aster DM Healthcare for Rs 1,530 crore
According to bulk deal data from BSE, Olympus Capital Asia Investments sold 4.50 crore shares, equivalent to a 9% stake in Aster DM Healthcare, in two tranches. The shares were sold within the price range of Rs 340 to Rs 340.13 each, totalling Rs 1,530.08 crore.
Private equity firm Olympus to sell upto 10% stake in Aster DM Healthcare on Friday
Olympus Capital Asia Investments is set to trim its stake in Aster DM, with a base offering of 2.5 crore shares, representing 5% of the company. Olympus currently holds a 10.1% stake in Aster DM.
Q4 results: Stable costs boost India Inc. profits
Steady costs and firm domestic demand supported corporate performance in the March quarter.
ET Analysis: Indian hospital chains report revenue growth & expansion plans amidst regulatory concerns
Leading hospital chains in India have reported improved average revenue per operating bed (ARPOB) and profitability in the latest quarter, driven by better payer mix and cost control measures. Expansion plans are underway, with a focus on markets like Bengaluru and Mumbai, through asset-light models. Adjacent businesses such as diagnostics, virtual care, and digital healthcare platforms are also seeing growth. However, regulatory proposals to rationalize rates may pose risks to sector valuations.
Apollo Hospitals Q4 Results: Net profit rises 76% YoY to Rs 254 crore
Revenue grew 15% YoY to Rs.4,944 crore in Q4FY24. The earnings before interest, tax, depreciation and ammortisation (EBITDA), EBITDA rose 31% YoY to Rs.640 crore in Q4FY24. The EBITDA margins expanded 161 basis points YoY to 12.95%.
Apollo Hospitals Q4 Results: Net profit soars 77% YoY to Rs 258 crore; revenue jumps 15%
Apollo Hospitals Q4 Results: Revenue from operations for the January-March 2024 period increased 15% YoY to Rs 4,944 crore. The company's board has recommended a final dividend of Rs 10 per share for FY24. EBITDA for the fourth quarter stood at Rs 640 crore in the reporting March quarter, compared with Rs 488 crore in the same quarter a year earlier.
- Go To Page 1
3M India Q4 Results: 'Post-it' maker posts profit rise; shares surge
3M INDIA-RESULTS/'Post-it' maker 3M India posts Q4 profit rise; shares surge
IRCTC, ABFRL, JSW Holdings among 453 companies declaring Q4 results on Tuesday
453 companies, including IRCTC and Aditya Birla Fashion, are set to declare Q4 results. Most companies report profits, boosting Nifty and Sensex to new highs. Market bullish ahead of Lok Sabha elections.
Q4 results this week: Tata Steel, LIC, IRCTC, Apollo Hospitals Enterprise, and Bharat Dynamics
Several companies, including Tata Steel, LIC, and IRCTC, will release their March quarter report cards this week.
Q4 results today: ITC, IndiGo among 181 companies to announce earnings on Thursday
181 companies, including IndiGo and ITC, will announce their quarterly earnings for Jan-Mar 2024. IndiGo is expected to post healthy earnings, while ITC may see muted revenue growth.
Max Healthcare Institute Q4 Results: PAT down 3% YoY to Rs 311 crore
Max Healthcare Institute Ltd on Wednesday reported a 2.81 per cent decline in profit after tax at Rs 311 crore in the fourth quarter ended March 31, 2024. The company had posted a Profit After Tax (PAT) of Rs 320 crore in the same quarter of the previous fiscal, Max Healthcare Institute said in a statement.
Max Healthcare Q4 Results: Net profit drops 3% YoY to Rs 311 crore
Max Healthcare's Q4FY24 net profit dips 3% YoY to Rs 311 crore, attributed to lower effective tax rate in Q4FY23 and new unit losses. Gross revenue rises 15% YoY to Rs 1,890 crore.
Global Health Q4 Results: Net profit rises 25% to Rs 127 crore
For the year ended on March 31, 2024, the company said its net profit increased to Rs 478 crore as against Rs 326 crore in FY23.
Mankind Pharma Q4 Results: Net profit jumps 62% YoY to Rs 477 crore
Mankind Pharma on Wednesday reported 62% year-on-year (YoY) jump in net profit to Rs 477 crore in Q4FY24 led by strong domestic formulation sales and one-off US export opportunities.
GE HealthCare Q1 Results: Co misses quarterly revenue estimates on weakness in China market
GE HealthCare Technologies missed first-quarter revenue estimates on Tuesday, hurt by lower sales in China market and weaker-than-expected demand for its scanning devices, sending its shares tumbling as much as 12% before the bell.
LTIMindtree shares drop 2.5% after disappointing Q4 results. Should you buy?
On Thursday, shares of the IT service company LTIMindtree dipped 2.5% to touch the day's low at Rs 4,611 on the BSE, as the company's Q4 results failed to meet market expectations.
Wipro Q4 Results: Profit falls 8% YoY to Rs 2,835 crore, marginally misses estimates
Wipro Q4 Results: Wipro reported an 8% YoY decrease in net profit to Rs 2,835 crore for the quarter ended March 2024. PAT is slightly below estimates. Operating margins at 16.4%. Future outlook optimistic with a focus on AI transformation.
Stocks in news: TCS, Anand Rathi, Aster DM, Bharti Hexacom, Varun Beverages
IT bellwether TCS reported better than expected numbers for the fourth quarter ended March as its profit rose 9% year-on-year to Rs 12,434 crore. Revenue from operations, meanwhile, jumped 3.5% year-on-year.
Olympus Capital Asia divests 9.8% stake in Aster DM Healthcare for Rs 1,978 cr
According to the bulk deal data available with the BSE, more than 4.42 crore equity shares of Aster DM Healthcare were sold by Olympus Capital Asia Investments and 45.59 lakh shares by Olympus ACF Pte Ltd of the company. In a separate deal, Capital Group acquired shares of Aditya Vision, a financial services company, for Rs 95 crore.
Aster DM shares fall 7% after PE firm Olympus likely offloaded 10% stake via block deal
Aster DM shares were trading amid strong volumes with nearly 59 lakh shares being traded on the NSE around 10:45 am and the total traded value of the shares standing at Rs 242.50 crore.
Stocks in news: Angel One, CDSL, Apollo Pipes, Cipla, Aster DM Healthcare
Equity indices declined on Tuesday. Angel One, CDSL, Apollo Pipes, Cipla, Aster DM Healthcare among top stocks to track today.
Aster DM Healthcare Q3 Results: Net profit rises 29% at Rs 179 crore
Aster DM Healthcare on Friday said its consolidated net profit increased 29 per cent to Rs 179 crore in the third quarter ended December 2023. The healthcare provider had reported a net profit of Rs 139 crore in the year-ago period.
Aster DM shareholders approve sale of Gulf business
Aster DM Healthcare last week said its board is considering plans to distribute to shareholders about 70-80% of the $903 million it will get by selling its Gulf business, translating into a dividend to its shareholders in the range of Rs 110/- to Rs 120/- per share, days after a proxy advisory firm Institutional Investor Advisory Services India (IiAS) has asked investors to veto the deal.
Aster DM to consider paying Rs 110-120 dividend from proceeds of gulf business sale
The board of directors held a meeting earlier on Monday to discuss the progress of the transaction between Affinity Holdings and Alpha GCC Holdings for segregation of the company’s GCC business.
Proxy advisor against Aster DM Healthcare's gulf deal
Aster DM has proposed two resolutions - the sale of its GCC business to Alpha GCC, a related party transaction, and the sale of subsidiary Affinity Holdings to Alpha GCC. The e-voting, which began on December 24, will end on January 24.
Aster DM Healthcare to set up 55-acre solar project to power seven hospitals in Kerala
Aster DM Healthcare has announced plans to build a 55-acre solar plant in Kasargod, India, aimed at powering seven hospitals in Kerala. The project, part of the company's sustainable healthcare practices, is expected to produce 10 MW of power, with the first phase covering a 27-acre plot set for completion by March 2024.
Max Healthcare Q2 Results: Net profit zooms 26% YoY to Rs 338 crore
The earnings before interest, tax, depreciation and ammortisation (EBITDA) increased 21% YoY to Rs 497 crore. The EBITDA margin improved 100 basis points YoY to 28.7%.
Max Healthcare Institute Q2 Results: Profit rises 27% YoY to Rs 338 crore
The company said all hospitals improved their average revenue per operating bed (ARPOB) during the period and the overall average growth in ARPOB stood at 13 per cent year-on-year (YoY). During the quarter, international patient revenue grew by 25 per cent as compared to the year-ago period, and the share of international patient revenues stood at 9 per cent of the hospital revenue during the quarter, it added.
Aster DM Healthcare, 2 other stocks with RS trending up
In this article, we explore the Relative Strength Index (RSI) and its significance in assessing stock movements. We delve into three stocks that are currently trending up, providing insights for potential investors.
Load More